Please wait
0001590877424B5EX-FILING FEESCommon Stock, par value $0.0001 per share00 0001590877 2024-12-09 2024-12-09 0001590877 1 2024-12-09 2024-12-09 iso4217:USD xbrli:pure
Exhibit 107
Calculation of Filing Fee Tables
424(b)(5)
(Form Type)
REGENXBIO Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
 
                         
    
Security
Type
  
Security
Class
Title
  
Fee
Calculation
or Carry
Forward
Rule
  
Amount
Registered 
  
Proposed
Maximum
Offering
Price Per
Unit
  
Maximum
Aggregate
Offering
Price
  
Fee
Rate
  
Amount of
Registration
Fee
  
Carry
Forward 
Form
Type
  
Carry
Forward 
File
Number
  
Carry
Forward 
Initial
Effective
Date
  
Filing Fee
Previously
Paid In
Connection 
with Unsold 
Securities to 
be Carried
Forward
 
Newly Registered Securities
                         
Fees to be
Paid
   Equity   
Common Stock, par value $0.0001  per share
   Rule 457(o) and 457(r)
 (1)
 		   N/A   N/A   $150,000,000    0.00015310    $22,965.00           
                         
Fees
Previously
Paid
   N/A   N/A   N/A   N/A   N/A   N/A     N/A          
 
Carry Forward Securities
                         
Carry
Forward
Securities
   N/A   N/A   N/A   N/A   N/A   N/A     N/A          
                   
   
Total Offering Amounts 
     $150,000,000     $22,965.00          
                   
   
Total Fees Previously Paid 
        
N/A
          
                   
   
Total Fee Offsets 
        
N/A
          
                   
   
Net Fee Due 
               $22,965.00                
 
(1)
The filing fee is calculated and is being paid pursuant to Rules 456(o) and 457(r) under the Securities Act of 1933, as amended (the “Securities Act”), based on the proposed maximum aggregate offering price. The registrant initially deferred payment of the registration fees for its Registration Statement on Form
S-3
(File
No. 333-269086)
filed by the Registrant with the Securities and Exchange Commission on December 30, 2022 pursuant to Rules 456(b) and 457(r) under the Securities Act.